Paragraph 24 Refusal of a marketing authorisationI1

the data submitted with the application are inadequate;

the risk-benefit balance of the veterinary medicinal product is unfavourable;

the product has insufficient therapeutic effect;

the withdrawal period proposed by the applicant is not long enough to ensure that Council Regulation (EEC) No. 2377/90 is complied with, or is insufficiently substantiated;

the veterinary medicinal product is for a prohibited use;

the way that the product will be used will have an unnecessarily undesirable effect on the environment.

if there is Community legislation pending that is incompatible with the requested authorisation; or

if he requests additional data and those data are not provided within such time limit as he may stipulate.